Japer Therapeutics Warrants
JSPRW
5 hedge funds and large institutions have $193K invested in Japer Therapeutics Warrants in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
14.55% less ownership
Funds ownership: 20.73% → 6.18% (-15%)
69% less capital invested
Capital invested by funds: $626K → $193K (-$433K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
+$4.42K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$541 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$4.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Walleye Capital
New York
| $120K | -$4.7K | -22,374 | -4% |
|
|
TCM
2
Tenor Capital Management
New York
| $52.4K | – | – | – |
|
|
ZA
3
Zazove Associates
Incline Village,
Nevada
| $12.4K | – | – | – |
|
|
4
Walleye Trading
New York
| $7.38K | +$4.42K | +21,043 | +149% |
|
|
5
UBS Group
Zurich,
Switzerland
| $437 | +$541 | +2,572 | New |
|
|
CAC
6
Cowen and Company
New York
| – | -$441K | -2,206,248 | Closed |
|
JSPRW Hedge Fund Activity: Q4 2024 in Review
5 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q4 2024, worth a combined $193K — down 69% from $626K a quarter earlier.
Fund positioning in JSPRW was balanced in Q4 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Walleye Trading, adding an estimated $4.42K. The largest seller was Walleye Capital, cutting an estimated $4.7K.
- 5 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $193K of Japer Therapeutics Warrants stock for Q4 2024, down 69% quarter-over-quarter.
- 1 fund opened new Japer Therapeutics Warrants positions in Q4 2024 and 1 closed out, a net change of 0 holders.
- The largest Japer Therapeutics Warrants buyer in Q4 2024 was Walleye Trading, an estimated $4.42K added.
- The largest Japer Therapeutics Warrants seller in Q4 2024 was Walleye Capital, an estimated $4.7K sold.
Based on aggregated 13F filings for Q4 2024.